Beyond the Needle: Redefining the Assessment of Lupus Nephritis Lupus nephritis is one of the most silent and severe manifestations of systemic lupus erythematosus (SLE). https://t.co/JD6z4VTfJn #ACR24 https://t.co/7gEK8acRl0

• Beyond the Needle: Redefining the Assessment of Lupus Nephritis | RheumNow

💊Litifilimab- another new molecule for SLE Anti BDCA2 🎯 In cutaneous lupus👉 👉Decrease CLASI score 👉Decrease IFN induced MxA expression #ACR2024 #ACRAmbassador https://t.co/AeJOGhVXIR

• https://x.com/RitasmanB/status/1859792066597040482/photo/1

🌟IgG4RD: Lessons from the first 20 years🌟by Prof John Stone ⭐️Lesson 1- IgG4RD is a variable vessel vasculitis ✨Can cause small vessel vasculitis of the skin ✨One of few vasculitis causing coronary arteritis in adults ⭐️Lesson 2- IgG4RD is more common and severe in males… https://t.co/PvFXyOl5bp https://t.co/hAMelBoZvB

• https://x.com/i/web/status/1859825372142952675
• https://x.com/darpan06T/status/1859825372142952675/photo/1
• https://x.com/darpan06T/status/1859825372142952675/photo/1
• https://x.com/darpan06T/status/1859825372142952675/photo/1
• https://x.com/darpan06T/status/1859825372142952675/photo/1

Differential diagnosis of ACA+ 1. SSc 2. Sjogren Syndrome 3. PBC 4. Overalp syndrome https://t.co/JmqDaaZerJ

• https://x.com/sclerodermaUM/status/1860276506460561776/photo/1

⏩Lecture by Prof Takeuchi on Sjogren Syndrome. Anti-centromere ab is seen in 10% of primary Sjogren syndrome. more likely to have sclerodactyly. https://t.co/mVry2OaNmq @IRACON24Blr https://t.co/SZlWQDpx8B

• Clinical and Immunological Features of Anti-centromere Antibody-Positive Primar…
• https://x.com/sclerodermaUM/status/1860276499414163685/photo/1

New #OAC #BasicScience This work by Shakya et al. found that basic calcium phosphate crystals are almost exclusively found in menisci from OA patients, while calcium pyrophosphate has similar prevalence in menisci from subjects with and without OA. 🔗 : https://t.co/PBaVQSspiE https://t.co/ivOOKVIX9b

• Prevalence and classification of meniscal calcifications in the human knee
• https://x.com/OACJournal/status/1859733787527000221/photo/1

PsA Ultrasound Updates Dr. Catherine Bakewell and Dr. Lihi Eder discuss updates on ultrasound in psoriatic arthritis at #ACR2024 https://t.co/XJOuKl8lCF https://t.co/XPMlf3sOnU

• PsA Ultrasound Updates | RheumNow

Day 1 Recap at #ACR24 Panelists Dr. Sheila Reyes, Dr. Adela Castro, Dr. Mike Putman and Dr. Jack Cush recap the most interesting abstracts and presentations they saw on day 1 of ACR 2024. https://t.co/8M0WhOLETg https://t.co/hW5cgRiy6F

• Day 1 Recap at ACR24 | RheumNow

Improving fertility in women with RA For women with rheumatoid arthritis (RA), the journey to motherhood brings unique challenges, such as longer times to conception and infertility rates twice as high as those without RA. Factors like high disease activity, regular use of… https://t.co/9QXgeB7ftB https://t.co/mVUabSdLNE

Sex related differences in PsA Different factors are known to influence disease characteristics and outcomes in psoriatic arthritis (PsA). Recently, there is new evidence that sex-related differences play a role not only in disease manifestations but also in efficacy and safety… https://t.co/9z9lorLtp0 https://t.co/XZRvm0S585

Playing it Safe with RA? JAK vs. TNF Debate The ORAL surveillance trial raised safety concerns that the janus kinase inhibitor (JAKi) tofacitinib was associated with an increased incidence of cancer and major adverse cardiovascular events (MACE), compared to tumor necrosis… https://t.co/sUSdRKRxEF https://t.co/XcjOqGlLVX

Cognitive Impairment: The Hidden Burden in Lupus Care Suppose you have a patient with SLE returning for follow-up. Their joint symptoms are well controlled. The kidneys—managed with a combination of biologic DMARD and mycophenolate—show no signs of active urinary sediment or… https://t.co/W8RO5aOaxj https://t.co/EF9P93hdPB

Assessing ASAS Criteria: CLASSIC Study Results Dr. Adela Castro discusses abstract 0820, presented at #ACR24 https://t.co/rlzL8nAsiI https://t.co/7lbXWE3gdJ

• Assessing ASAS Criteria: CLASSIC Study Results | RheumNow

RheumNow’s expanded coverage of the #ACR24 annual meeting is sponsored in part by Novartis. Content is chosen by RheumNow & its facult.y

Cycling vs Switching after TNFi Failure in axSpA Dr. Lihi Eder discusses abstract 0603, presented at #ACR24 https://t.co/qkDuutgqvv https://t.co/Agqopk6bh2

• Cycling vs Switching after TNFi Failure in axSpA | RheumNow